News | Mammography | January 16, 2019

Digital Mammography Increases Breast Cancer Detection

U.K. study evaluates more than 11 million screening mammograms

Digital Mammography Increases Breast Cancer Detection

January 16, 2019 — The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United Kingdom without increasing the recall rate, according to a major new study appearing in the journal Radiology.1

Digital mammography was introduced into clinical use more than 15 years ago and has been widely adopted due to the numerous advantages it has over its predecessor, screen film mammography.

“Image quality with digital mammography is improved over that of screen film mammography,” said radiologist and study coauthor Rosalind M. Given-Wilson, MBBS, from St. Georges University Hospitals NHS Foundation Trust in London. “In particular, digital mammography provides the ability to visualize calcifications and see through denser tissue, and it allows the reader to adjust the image.”

Given-Wilson and colleagues assessed digital mammography’s impact on cancer detection using data from the 80 facilities of the English National Health Service Breast Cancer Screening Program. The huge trove of data combined with estimates of digital mammography usage enabled the researchers to measure the effect of digital mammography in 11.3 million screening exams in women between the ages of 45 and 70.

The overall cancer detection rate was 14 percent greater with digital mammography, with substantially higher detection of grade 1 and grade 2 invasive cancers — early-stage cancers that could advance to life-threatening disease if not detected and treated early enough.

At first screening exams for women aged 45 to 52, digital mammography increased the overall detection rate by 19 percent. Importantly, the higher sensitivity of digital mammography did not increase the recall rate — the rate at which women are called back for additional screening based on suspicious results.

“This improvement happened in the absence of other changes in the English screening program, such as a change in recall rate or introduction of computer-aided detection, so we can be clear that the increased rate of detection is due to the change in technology,” Given-Wilson said.

Digital mammography increased the detection of some types of cancers more than others. For instance, digital mammography significantly increased the detection of ductal carcinoma in situ (DCIS), an early-stage cancer confined to the milk ducts of the breast, at both first screens and subsequent screens.

“These results confirm that digital mammography is superior to screen film mammography in finding invasive cancers and DCIS,” Given-Wilson said. “Women are more likely to have a cancer detected with a digital mammogram.”

While digital mammography improved detection of grade 1 and 2 cancers, the researchers found no improvement in the detection of grade 3 invasive cancers. Grade 3 cancers are faster-growing and more likely to spread than grade 1 and 2 cancers.

The researchers are looking at the radiological features of grade 3 cancers on digital mammography to see if optimizing the image for these lesions, which are often nonspecific and ill-defined soft tissue densities, can aid detection. They are also studying the relationship between grade 3 cancers and subsequent interval cancers, or cancers that appear between screenings.

For more information: www.pubs.rsna.org/journal/radiology

Reference

1. Blanks R.G., Wallis M.G., Alison R., et al. Impact of Digital Mammography on Cancer Detection and Recall Rates: 11.3 Million Screening Episodes in the English National Health Service Breast Cancer Screening Program. Radiology, Dec. 11, 2018. https://doi.org/10.1148/radiol.2018181426

Related Content

Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
 Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles
Technology | Breast Density | January 31, 2019
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...